Document Detail


Greasing the wheels of managing overweight and obesity with omega-3 fatty acids.
MedLine Citation:
PMID:  21981905     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The epidemic of overweight and obesity around the world and in the US is a major public health challenge, with 1.5 billion overweight and obese adults worldwide, and 68% of US adults and 31% of US children and adolescents overweight or obese. Obesity leads to serious health consequences, including an increased risk of type 2 diabetes mellitus and heart disease. Current preventive and medical treatments include lifestyle modification, medication, and bariatric surgery in extreme cases; however, they are either not very efficacious or are very expensive. Obesity is a complex condition involving the dysregulation of several organ systems and molecular pathways, including adipose tissue, the pancreas, the gastrointestinal tract, and the CNS. The role of the CNS in obesity is receiving more attention as obesity rates rise and treatments continue to fail. While the role of the hypothalamus in regulation of appetite and food intake has long been recognized, the roles of the CNS reward systems are beginning to be examined as the role of environmental influences on energy balance are explored. Omega-3 polyunsaturated fatty acids are essential nutrients that play a beneficial role in several disease processes due to their anti-inflammatory effects, modulation of lipids, and effects on the CNS. Omega-3 fatty acids, specifically EPA and DHA, have shown promising preliminary results in animal and human studies in the prevention and treatment of obesity. Given their effects on many of the pathways involved in obesity, and specifically in the endocannabinoid and mesocorticolimbic pathways, we hypothesize that EPA and DHA supplementation in populations can reduce the reward associated with food, thereby reduce appetite and food intake, and ultimately contribute to the prevention or reduction of obesity. If these fatty acids do harbor such potential, their supplementation in many parts of the world may hold great promise in reducing the global burden of obesity.
Authors:
N Golub; D Geba; S A Mousa; G Williams; R C Block
Related Documents :
23741185 - Microbiological profile and nutritional quality of raw foods for neutropenic patients u...
9632515 - Position of operant costs affects visits to resources by laboratory mice, mus musculus.
23391015 - Fermented milks and milk products as functional foods-a review.
21172395 - "watching a person who knows how to cook, you'll learn a lot". linked lives, cultural t...
18171175 - When dinner is dangerous: toxic frogs elicit species-specific responses from a generali...
941195 - Human urinary and liver conjugates of 17alpha-ethnylestradiol.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2011-10-06
Journal Detail:
Title:  Medical hypotheses     Volume:  77     ISSN:  1532-2777     ISO Abbreviation:  Med. Hypotheses     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-07     Completed Date:  2012-03-06     Revised Date:  2014-09-14    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1114-20     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Appetite Depressants / therapeutic use*
Disease Management*
Docosahexaenoic Acids
Eating / drug effects*
Eicosapentaenoic Acid
Fatty Acids, Omega-3 / therapeutic use*
Humans
Models, Biological*
Obesity / drug therapy*
Grant Support
ID/Acronym/Agency:
R21 HL102582/HL/NHLBI NIH HHS; R21 HL102582-01/HL/NHLBI NIH HHS; R21 HL102582-02/HL/NHLBI NIH HHS; UL1 RR024160/RR/NCRR NIH HHS; UL1 RR024160/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Appetite Depressants; 0/Fatty Acids, Omega-3; 25167-62-8/Docosahexaenoic Acids; AAN7QOV9EA/Eicosapentaenoic Acid
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatotoxicity and liver enzyme alteration in patients with immunobullous diseases receiving immunos...
Next Document:  Joint hypermobility in children with idiopathic scoliosis: SOSORT award 2011 winner.